On November 30, 2023, BrightPath Biotherapeutics Co., Ltd. closed the transaction.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
58 JPY | +1.75% | -1.69% | -33.33% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
189.9 AUD | -0.10% | -0.64% | 45.84B | ||
58 JPY | +1.75% | -1.69% | 25.81M | ||
1st Jan change | Capi. | |
---|---|---|
-33.33% | 25.81M | |
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+42.27% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |
- Stock Market
- Equities
- 4594 Stock
- News BrightPath Biotherapeutics Co., Ltd.
- BrightPath Biotherapeutics Co., Ltd. announced that it has received ¥5.1678 million in funding from Macquarie Group Limited